These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6195793

  • 1. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
    Behrendt H, Ringert RH, Pfeiffer R, Homann W, Hartung R.
    Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
    [Abstract] [Full Text] [Related]

  • 2. [Staging of testicular cancer by ultrasound and tumor markers with special respect to stage I and IIA].
    Behrendt H, Heckemann R, Meyer-Schwickerath M, Hartung R.
    Urol Int; 1983; 38(5):279-84. PubMed ID: 6195792
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Progress in the therapy of testicular teratoid tumors].
    Seeber S.
    Wien Med Wochenschr; 1982 Jul 31; 132(13-14):329-33. PubMed ID: 6182701
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The place of surgery in the treatment of seminomatous testicular tumors.
    Smith RB.
    Prog Clin Biol Res; 1984 Jul 31; 153():111-9. PubMed ID: 6206504
    [Abstract] [Full Text] [Related]

  • 7. [Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase].
    Schwarz HP, Susani M, Kratzik C, Studler G, Krisch K, Aiginger P.
    Wien Klin Wochenschr; 1984 Mar 16; 96(6):230-4. PubMed ID: 6204462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD, Patel MI, Sheinfeld J.
    J Urol; 2004 Jan 16; 171(1):168-71. PubMed ID: 14665869
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ, Williams JJ.
    Urology; 1982 Jul 16; 20(1):50-2. PubMed ID: 6180542
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemistry of germ cell tumors of the testis. Study of beta HCG and AFP.
    Caillaud JM, Bellet D, Carlu C, Droz JP.
    Prog Clin Biol Res; 1985 Jul 16; 203():139-40. PubMed ID: 2421327
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
    Steyerberg EW, Keizer HJ, Sleijfer DT, Fossâ SD, Bajorin DF, Gerl A, de Wit R, Kirkels WJ, Koops HS, Habbema JD.
    Radiology; 2000 May 16; 215(2):437-44. PubMed ID: 10796922
    [Abstract] [Full Text] [Related]

  • 17. Germ cell tumours of the testis.
    Risdon RA.
    J Pathol; 1983 Nov 16; 141(3):355-61. PubMed ID: 6198501
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR, Belitsky P, Millard OH, Lannon SG.
    Can J Surg; 1993 Dec 16; 36(6):537-40. PubMed ID: 7504978
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-seminoma stage III. Current possibilities of "salvage" chemotherapy.
    Schmidt CG.
    Prog Clin Biol Res; 1984 Dec 16; 153():201-18. PubMed ID: 6206506
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.